Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyBiologicalProcess	postsynaptic density organization	SHANK1 LRFN1 SYNGAP1 PTPRS FGFR1 CDH2	3.13e-06	58	144	6	GO:0097106
GeneOntologyBiologicalProcess	postsynaptic specialization organization	SHANK1 LRFN1 SYNGAP1 PTPRS FGFR1 CDH2	1.03e-05	71	144	6	GO:0099084
GeneOntologyBiologicalProcess	regulation of postsynaptic density organization	LRFN1 PTPRS FGFR1 CDH2	3.53e-05	27	144	4	GO:1905874
GeneOntologyCellularComponent	catenin complex	CDH22 CTNND1 CDH2 CDH4	7.24e-05	32	147	4	GO:0016342
Domain	fn3	BOC COL7A1 LRFN1 TSPOAP1 OBSCN PTPRJ PTPRS IL27RA	3.05e-05	162	140	8	PF00041
Domain	IGc2	A1BG BOC LRFN1 OBSCN FCRL6 LRIG2 PTPRS VSIG10L FGFR1	7.12e-05	235	140	9	SM00408
Domain	Ig_sub2	A1BG BOC LRFN1 OBSCN FCRL6 LRIG2 PTPRS VSIG10L FGFR1	7.12e-05	235	140	9	IPR003598
Domain	FN3	BOC COL7A1 LRFN1 TSPOAP1 OBSCN PTPRJ PTPRS IL27RA	7.81e-05	185	140	8	SM00060
Domain	Ig-like_fold	A1BG BOC ISLR2 COL7A1 LRFN1 TSPOAP1 OBSCN NFAM1 FCRL6 LRIG2 PTPRJ PTPRS VSIG10L FGFR1 IGLL1 IL27RA	8.00e-05	706	140	16	IPR013783
Domain	FN3	BOC COL7A1 LRFN1 TSPOAP1 OBSCN PTPRJ PTPRS IL27RA	1.30e-04	199	140	8	PS50853
Domain	-	A1BG BOC ISLR2 COL7A1 LRFN1 TSPOAP1 OBSCN FCRL6 LRIG2 PTPRJ PTPRS VSIG10L FGFR1 IGLL1 IL27RA	1.38e-04	663	140	15	2.60.40.10
Domain	FN3_dom	BOC COL7A1 LRFN1 TSPOAP1 OBSCN PTPRJ PTPRS IL27RA	1.82e-04	209	140	8	IPR003961
Domain	IG_LIKE	A1BG BOC ISLR2 LRFN1 OBSCN NFAM1 FCRL6 LRIG2 PTPRS VSIG10L FGFR1 IGLL1	3.31e-04	491	140	12	PS50835
Domain	IG	A1BG BOC ISLR2 LRFN1 OBSCN NFAM1 FCRL6 LRIG2 PTPRS VSIG10L FGFR1	3.36e-04	421	140	11	SM00409
Domain	Ig_sub	A1BG BOC ISLR2 LRFN1 OBSCN NFAM1 FCRL6 LRIG2 PTPRS VSIG10L FGFR1	3.36e-04	421	140	11	IPR003599
Domain	Ig-like_dom	A1BG BOC ISLR2 LRFN1 OBSCN NFAM1 FCRL6 LRIG2 PTPRS VSIG10L FGFR1 IGLL1	4.11e-04	503	140	12	IPR007110
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	LRFN1 SETD1B MAN2B1 SH3RF1 PPRC1 PHF12 OBSCN SREBF1 POLRMT CHRM4 KIFC2 PKMYT1 HIVEP3 RADIL ADAMTSL5 PTPRS LRRC56 MAP3K11 FGFR1 ARRDC2 HR	2.70e-08	1105	156	21	35748872
Pubmed	Overlapping and divergent signaling pathways of N-cadherin and VE-cadherin in endothelial cells.	PTPRJ CTNND1 CDH2	3.53e-07	4	156	3	22246030
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	CDC42BPG MAGED1 MAN2B1 ARHGAP23 SREBF1 SLC35E1 POLRMT SYDE1 FAM111B TTLL12 FREM2 RECQL4 HR RAVER1	1.54e-06	650	156	14	38777146
Pubmed	Expression of the immunoglobulin superfamily cell adhesion molecules in the developing spinal cord and dorsal root ganglion.	A1BG BOC ISLR2 LRFN1 OBSCN LRIG2 PTPRS	9.09e-06	162	156	7	25826454
Pubmed	Exome sequencing reveals pathogenic mutations in 91 strains of mice with Mendelian disorders.	ANK1 FREM2 NDC1 FGFR1 PLD4	1.87e-05	72	156	5	25917818
Pubmed	Localization of ank1.5 in the sarcoplasmic reticulum precedes that of SERCA and RyR: relationship with the organization of obscurin in developing sarcomeres.	ANK1 OBSCN	2.00e-05	2	156	2	19002483
Pubmed	Molecular cloning of mouse pancreatic islet R-cadherin: differential expression in endocrine and exocrine tissue.	CDH2 CDH4	2.00e-05	2	156	2	8247017
Pubmed	IL-27/IL-27 Receptor Signaling Provides Protection in Clostridium difficile-Induced Colitis.	IL27 IL27RA	2.00e-05	2	156	2	29140433
Pubmed	Interleukin-27-dependent transcriptome signatures during neonatal sepsis.	IL27 IL27RA	2.00e-05	2	156	2	36891292
Pubmed	Expression of WSX1 in tumors sensitizes IL-27 signaling-independent natural killer cell surveillance.	IL27 IL27RA	2.00e-05	2	156	2	19549909
Pubmed	IL-27 Mediates Pro-Inflammatory Effects via the ERK Signaling Pathway During Preterm Labor.	IL27 IL27RA	2.00e-05	2	156	2	34691022
Pubmed	Murine γ-Herpesvirus 68 Induces Severe Lung Inflammation in IL-27-Deficient Mice with Liver Dysfunction Preventable by Oral Neomycin.	IL27 IL27RA	2.00e-05	2	156	2	29500240
Pubmed	Essential role of obscurin kinase-1 in cardiomyocyte coupling via N-cadherin phosphorylation.	OBSCN CDH2	2.00e-05	2	156	2	38127465
Pubmed	Production of IL-27 in multiple sclerosis lesions by astrocytes and myeloid cells: Modulation of local immune responses.	IL27 IL27RA	2.00e-05	2	156	2	26649511
Pubmed	IL-27 abrogates receptor activator of NF-kappa B ligand-mediated osteoclastogenesis of human granulocyte-macrophage colony-forming unit cells through STAT1-dependent inhibition of c-Fos.	IL27 IL27RA	2.00e-05	2	156	2	19620301
Pubmed	IL-27 receptor signalling restricts the formation of pathogenic, terminally differentiated Th1 cells during malaria infection by repressing IL-12 dependent signals.	IL27 IL27RA	2.00e-05	2	156	2	23593003
Pubmed	Expression of RARRES1 and AGBL2 and progression of conventional renal cell carcinoma.	RARRES1 AGBL2	2.00e-05	2	156	2	32307444
Pubmed	Obscurin is a ligand for small ankyrin 1 in skeletal muscle.	ANK1 OBSCN	2.00e-05	2	156	2	12631729
Pubmed	Interleukin-27 inhibits ectopic lymphoid-like structure development in early inflammatory arthritis.	IL27 IL27RA	2.00e-05	2	156	2	26417004
Pubmed	Impaired Interleukin-27-Mediated Control of CD4+ T Cell Function Impact on Ectopic Lymphoid Structure Formation in Patients With Sjögren's Syndrome.	IL27 IL27RA	2.00e-05	2	156	2	32307922
Pubmed	IL-27 affects helper T cell responses via regulation of PGE2 production by macrophages.	IL27 IL27RA	2.00e-05	2	156	2	25088998
Pubmed	IL-27/IL-27R Mediates Protective Immunity against Chlamydial Infection by Suppressing Excessive Th17 Responses and Reducing Neutrophil Inflammation.	IL27 IL27RA	2.00e-05	2	156	2	33863788
Pubmed	IL-27 subunits and its receptor (WSX-1) mRNAs are markedly up-regulated in inflammatory cells in the CNS during experimental autoimmune encephalomyelitis.	IL27 IL27RA	2.00e-05	2	156	2	15850576
Pubmed	Mapping the binding site on small ankyrin 1 for obscurin.	ANK1 OBSCN	2.00e-05	2	156	2	17720975
Pubmed	IL-27 induces a Th1 immune response and susceptibility to experimental arthritis.	IL27 IL27RA	2.00e-05	2	156	2	18178832
Pubmed	N-cadherin is an in vivo substrate for protein tyrosine phosphatase sigma (PTPsigma) and participates in PTPsigma-mediated inhibition of axon growth.	PTPRS CDH2	2.00e-05	2	156	2	17060446
Pubmed	Identification of Interleukin-27 (IL-27)/IL-27 Receptor Subunit Alpha as a Critical Immune Axis for In Vivo HIV Control.	IL27 IL27RA	2.00e-05	2	156	2	28592538
Pubmed	P120-Catenin Regulates Early Trafficking Stages of the N-Cadherin Precursor Complex.	CTNND1 CDH2	2.00e-05	2	156	2	27254316
Pubmed	A soluble form of IL-27Rα is a natural IL-27 antagonist.	IL27 IL27RA	2.00e-05	2	156	2	24771852
Pubmed	IL-27 Signaling Is Crucial for Survival of Mice Infected with African Trypanosomes via Preventing Lethal Effects of CD4+ T Cells and IFN-γ.	IL27 IL27RA	2.00e-05	2	156	2	26222157
Pubmed	IL-27 regulates IL-10 and IL-17 from CD4+ cells in nonhealing Leishmania major infection.	IL27 IL27RA	2.00e-05	2	156	2	19748991
Pubmed	IL-27 alters inflammatory cytokine expression and limits protective immunity against Mycobacterium tuberculosis in a neonatal BCG vaccination model.	IL27 IL27RA	2.00e-05	2	156	2	38390338
Pubmed	IL-27 signaling compromises control of bacterial growth in mycobacteria-infected mice.	IL27 IL27RA	2.00e-05	2	156	2	15585875
Pubmed	Positive and negative regulation of the IL-27 receptor during lymphoid cell activation.	IL27 IL27RA	2.00e-05	2	156	2	15944269
Pubmed	Role of IL-27 in Epstein-Barr virus infection revealed by IL-27RA deficiency.	IL27 IL27RA	2.00e-05	2	156	2	38509369
Pubmed	Interleukin-27 signaling promotes immunity against endogenously arising murine tumors.	IL27 IL27RA	2.00e-05	2	156	2	23554861
Pubmed	IL-27 induces a pro-inflammatory response in human fetal membranes mediating preterm birth.	IL27 IL27RA	2.00e-05	2	156	2	28756371
Pubmed	Enhanced cell-cell contact stability and decreased N-cadherin-mediated migration upon fibroblast growth factor receptor-N-cadherin cross talk.	FGFR1 CDH2	2.00e-05	2	156	2	31312021
Pubmed	Functional cis-heterodimers of N- and R-cadherins.	CDH2 CDH4	2.00e-05	2	156	2	10662782
Pubmed	IL-27 regulates homeostasis of the intestinal CD4+ effector T cell pool and limits intestinal inflammation in a murine model of colitis.	IL27 IL27RA	2.00e-05	2	156	2	19596985
Pubmed	Increased IL-27/IL-27R expression in association with the immunopathology of murine ocular toxoplasmosis.	IL27 IL27RA	2.00e-05	2	156	2	29779048
Pubmed	IL27 Signaling Serves as an Immunologic Checkpoint for Innate Cytotoxic Cells to Promote Hepatocellular Carcinoma.	IL27 IL27RA	2.00e-05	2	156	2	35723626
Pubmed	Cutting edge: IL-27 is a potent inducer of IL-10 but not FoxP3 in murine T cells.	IL27 IL27RA	2.00e-05	2	156	2	18292493
Pubmed	Dynamic and static interactions between p120 catenin and E-cadherin regulate the stability of cell-cell adhesion.	CTNND1 CDH2	5.98e-05	3	156	2	20371349
Pubmed	IL-35 Suppresses Lipopolysaccharide-Induced Airway Eosinophilia in EBI3-Deficient Mice.	IL27 IL27RA	5.98e-05	3	156	2	27881708
Pubmed	The fibroblast growth factor receptor acid box is essential for interactions with N-cadherin and all of the major isoforms of neural cell adhesion molecule.	FGFR1 CDH2	5.98e-05	3	156	2	17005551
Pubmed	Compartmentalization in membrane rafts defines a pool of N-cadherin associated with catenins and not engaged in cell-cell junctions in melanoma cells.	CTNND1 CDH2	5.98e-05	3	156	2	17668445
Pubmed	Interleukin-27 Is Essential for Type 1 Diabetes Development and Sjögren Syndrome-like Inflammation.	IL27 IL27RA	5.98e-05	3	156	2	31801074
Pubmed	FGFR1 and FGFR4 oncogenicity depends on n-cadherin and their co-expression may predict FGFR-targeted therapy efficacy.	FGFR1 CDH2	5.98e-05	3	156	2	32114392
Pubmed	N-cadherin/p120 catenin association at cell-cell contacts occurs in cholesterol-rich membrane domains and is required for RhoA activation and myogenesis.	CTNND1 CDH2	5.98e-05	3	156	2	19546217
Pubmed	CYP1B1 promotes tumorigenesis via altered expression of CDC20 and DAPK1 genes in renal cell carcinoma.	CYP1B1 CDC20	5.98e-05	3	156	2	26626260
Pubmed	Oral Escherichia coli colonization factor antigen I fimbriae ameliorate arthritis via IL-35, not IL-27.	IL27 IL27RA	5.98e-05	3	156	2	24337375
Pubmed	IL-27 is required for shaping the magnitude, affinity distribution, and memory of T cells responding to subunit immunization.	IL27 IL27RA	5.98e-05	3	156	2	25267651
Pubmed	Cross-link regulation of precursor N-cadherin and FGFR1 by GDNF increases U251MG cell viability.	FGFR1 CDH2	5.98e-05	3	156	2	29750313
Pubmed	IL-27 regulates the number, function and cytotoxic program of antiviral CD4 T cells and promotes cytomegalovirus persistence.	IL27 IL27RA	5.98e-05	3	156	2	30044874
Pubmed	Structural insights into the assembly and activation of the IL-27 signaling complex.	IL27 IL27RA	5.98e-05	3	156	2	35920255
Pubmed	Interleukin-27 receptor limits atherosclerosis in Ldlr-/- mice.	IL27 IL27RA	5.98e-05	3	156	2	22927332
Pubmed	Lack of Immunomodulatory Interleukin-27 Enhances Oncogenic Properties of Mutant p53 In Vivo.	IL27 IL27RA	5.98e-05	3	156	2	26979394
Pubmed	Interleukin-27 controls basal pain threshold in physiological and pathological conditions.	IL27 IL27RA	5.98e-05	3	156	2	30038376
Pubmed	Expression of inappropriate cadherins by epithelial tumor cells promotes endocytosis and degradation of E-cadherin via competition for p120(ctn).	CTNND1 CDH4	5.98e-05	3	156	2	16786001
Pubmed	Binding of an ankyrin-1 isoform to obscurin suggests a molecular link between the sarcoplasmic reticulum and myofibrils in striated muscles.	ANK1 OBSCN	5.98e-05	3	156	2	12527750
Pubmed	Two-sided roles of IL-27: induction of Th1 differentiation on naive CD4+ T cells versus suppression of proinflammatory cytokine production including IL-23-induced IL-17 on activated CD4+ T cells partially through STAT3-dependent mechanism.	IL27 IL27RA	5.98e-05	3	156	2	17015723
Pubmed	IL-27 Facilitates Skin Wound Healing through Induction of Epidermal Proliferation and Host Defense.	IL27 IL27RA	5.98e-05	3	156	2	28132857
Pubmed	Blockade of interleukin-27 signaling reduces GVHD in mice by augmenting Treg reconstitution and stabilizing Foxp3 expression.	IL27 IL27RA	5.98e-05	3	156	2	27488350
Pubmed	A role for IL-27p28 as an antagonist of gp130-mediated signaling.	IL27 IL27RA	5.98e-05	3	156	2	21057510
Pubmed	Differential expression of neural cell adhesion molecule and cadherins in pancreatic islets, glucagonomas, and insulinomas.	CDH2 CDH4	5.98e-05	3	156	2	1406710
Pubmed	Tristetraprolin inhibits macrophage IL-27-induced activation of antitumour cytotoxic T cell responses.	IL27 IL27RA	5.98e-05	3	156	2	29021521
Pubmed	N-cadherin levels in endothelial cells are regulated by monolayer maturity and p120 availability.	CTNND1 CDH2	5.98e-05	3	156	2	18979298
Pubmed	Protein-tyrosine phosphatase expression in pre-B cell NALM-6.	PTPN7 PTPRS	5.98e-05	3	156	2	1370651
Pubmed	WSX1 act as a tumor suppressor in hepatocellular carcinoma by downregulating neoplastic PD-L1 expression.	IL27 IL27RA	5.98e-05	3	156	2	34108491
Pubmed	E-cadherin and APC compete for the interaction with beta-catenin and the cytoskeleton.	CTNND1 CDH2 CDH4	9.54e-05	20	156	3	7806582
Pubmed	Prediction of the coding sequences of unidentified human genes. XVII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	ISLR2 LRFN1 SH3RF1 ARHGAP23 PHF12	1.05e-04	103	156	5	10819331
Pubmed	Tolerogenic signals delivered by dendritic cells to T cells through a galectin-1-driven immunoregulatory circuit involving interleukin 27 and interleukin 10.	IL27 IL27RA	1.19e-04	4	156	2	19668220
Pubmed	Treg-specific IL-27Rα deletion uncovers a key role for IL-27 in Treg function to control autoimmunity.	IL27 IL27RA	1.19e-04	4	156	2	28874534
Pubmed	TANGO1 facilitates cargo loading at endoplasmic reticulum exit sites.	COL7A1 SEC23A	1.19e-04	4	156	2	19269366
Pubmed	SREBP-1 interacts with hepatocyte nuclear factor-4 alpha and interferes with PGC-1 recruitment to suppress hepatic gluconeogenic genes.	PPRC1 SREBF1	1.19e-04	4	156	2	14722127
Pubmed	Obscurin and KCTD6 regulate cullin-dependent small ankyrin-1 (sAnk1.5) protein turnover.	ANK1 OBSCN	1.19e-04	4	156	2	22573887
Pubmed	Hepatocyte growth factor receptor tyrosine kinase met is a substrate of the receptor protein-tyrosine phosphatase DEP-1.	PTPRJ CTNND1	1.19e-04	4	156	2	12475979
Pubmed	RET modulates cell adhesion via its cleavage by caspase in sympathetic neurons.	CTNND1 CDH2	1.19e-04	4	156	2	21357690
Pubmed	Population-based meta-analysis in Caucasians confirms association with COL5A1 and ZNF469 but not COL8A2 with central corneal thickness.	COL5A1 ZNF469	1.19e-04	4	156	2	22814818
Pubmed	Developmental defects in mouse embryos lacking N-cadherin.	CDH2 CDH4	1.19e-04	4	156	2	9015265
Pubmed	IL-27 promotes NK cell effector functions via Maf-Nrf2 pathway during influenza infection.	IL27 IL27RA	1.19e-04	4	156	2	30899058
Pubmed	Mapping the human genetic architecture of COVID-19.	PLEKHA4 RAVER1	1.19e-04	4	156	2	34237774
Pubmed	CYP17, SRD5A2, CYP1B1, and CYP2D6 gene polymorphisms with prostate cancer risk in North Indian population.	CYP1B1 CYP2D6	1.19e-04	4	156	2	16716118
Pubmed	WSX-1 and glycoprotein 130 constitute a signal-transducing receptor for IL-27.	IL27 IL27RA	1.19e-04	4	156	2	14764690
Pubmed	IL-27 Induced by Select Candida spp. via TLR7/NOD2 Signaling and IFN-β Production Inhibits Fungal Clearance.	IL27 IL27RA	1.19e-04	4	156	2	27259855
Pubmed	Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells.	IL27 IL27RA	1.19e-04	4	156	2	16906167
Pubmed	Palmitoylation of δ-catenin by DHHC5 mediates activity-induced synapse plasticity.	CTNND1 CDH2	1.19e-04	4	156	2	24562000
Pubmed	Killer cell lectin-like receptor G1 binds three members of the classical cadherin family to inhibit NK cell cytotoxicity.	CDH2 CDH4	1.19e-04	4	156	2	16461340
Pubmed	Cadherin-11 interacts with the FGF receptor and induces neurite outgrowth through associated downstream signalling.	FGFR1 CDH2	1.19e-04	4	156	2	18302981
Pubmed	Induction of complement-fixing autoantibodies against type VII collagen results in subepidermal blistering in mice.	COL7A1 HR	1.19e-04	4	156	2	16920988
Pubmed	IL-27 regulates IL-12 responsiveness of naive CD4+ T cells through Stat1-dependent and -independent mechanisms.	IL27 IL27RA	1.19e-04	4	156	2	14657353
Pubmed	Tumor suppressor RARRES1 interacts with cytoplasmic carboxypeptidase AGBL2 to regulate the α-tubulin tyrosination cycle.	RARRES1 AGBL2	1.19e-04	4	156	2	21303978
Pubmed	Loss of CHFR in human mammary epithelial cells causes genomic instability by disrupting the mitotic spindle assembly checkpoint.	CHFR CDC20	1.19e-04	4	156	2	18592005
Pubmed	IL-27 Limits Type 2 Immunopathology Following Parainfluenza Virus Infection.	IL27 IL27RA	1.19e-04	4	156	2	28129374
Pubmed	Persistent loss of IL-27 responsiveness in CD8+ memory T cells abrogates IL-10 expression in a recall response.	IL27 IL27RA	1.19e-04	4	156	2	23091017
Pubmed	IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4+ T cells.	IL27 IL27RA	1.19e-04	4	156	2	12121660
Pubmed	Two-hybrid analysis reveals multiple direct interactions for thrombospondin 1.	COL5A1 COL7A1	1.19e-04	4	156	2	9840442
Pubmed	Molecular interactions with obscurin are involved in the localization of muscle-specific small ankyrin1 isoforms to subcompartments of the sarcoplasmic reticulum.	ANK1 OBSCN	1.19e-04	4	156	2	16962094
Pubmed	Nutrient Transporter Gene Expression in the Early Conceptus-Implications From Two Mouse Models of Diabetic Pregnancy.	CPT1B SLC2A10 SLC27A5	1.89e-04	25	156	3	35478964
Interaction	IL27RA interactions	TMEM30B LRFN1 NDC1 LRP11 FGFR1 IL27 IL27RA	5.48e-07	67	146	7	int:IL27RA
Interaction	PLEKHA7 interactions	LRFN1 PLEKHA4 FAM53C SYDE1 ZMAT5 TESK2 FGFR1 CTNND1	2.49e-06	119	146	8	int:PLEKHA7
Interaction	SIPA1L1 interactions	LRFN1 POLD1 PLEKHA4 FAM53C SYDE1 GAB2 SYNGAP1 TESK2 TRIM37	5.08e-06	174	146	9	int:SIPA1L1
Interaction	CDK16 interactions	LRFN1 PLEKHA4 FAM53C SYDE1 GAB2 TESK2 FGFR1 SEC23A	5.41e-06	132	146	8	int:CDK16
Interaction	RTKN interactions	LRFN1 PLEKHA4 FAM53C SYDE1 GAB2 ACOT11 TESK2	2.07e-05	115	146	7	int:RTKN
Interaction	LRFN1 interactions	TMEM30B LRFN1 FAM53C SYDE1 GAB2 TESK2 IL27RA	3.37e-05	124	146	7	int:LRFN1
Interaction	TMEM30B interactions	TMEM30B LRFN1 PTPRS FGFR1 TMEM143 IL27RA	3.56e-05	85	146	6	int:TMEM30B
Interaction	ANKRD34A interactions	LRFN1 FAM53C SYDE1 GAB2 TESK2	4.04e-05	53	146	5	int:ANKRD34A
Cytoband	Ensembl 112 genes in cytogenetic band chr19q13	SHANK1 A1BG LRFN1 OVOL3 MBOAT7 POLD1 CCNP PLEKHA4 FAM83E PPP1R15A ADM5 HSPB6 VSIG10L TMEM143 SLC27A5	1.62e-05	1192	157	15	chr19q13
Cytoband	16p13.3	C1QTNF8 C16orf96 MCRIP2 PKMYT1 MMP25 PIGQ ZSCAN10	2.28e-05	244	157	7	16p13.3
Cytoband	Ensembl 112 genes in cytogenetic band chr22q13	CYP2D6 CPT1B NFAM1 TTLL8 SHISAL1 TTLL12 PRR34	1.51e-04	330	157	7	chr22q13
Cytoband	Ensembl 112 genes in cytogenetic band chr19p13	MAN2B1 SLC35E1 POLRMT SYDE1 ADAMTSL5 PTPRS FUT5 ARRDC2 IL27RA RAVER1	4.47e-04	797	157	10	chr19p13
Cytoband	19q13.33	PLEKHA4 FAM83E ADM5 TMEM143	4.99e-04	106	157	4	19q13.33
Cytoband	20q13.1	SLC2A10 CDH22	5.14e-04	10	157	2	20q13.1
Cytoband	Ensembl 112 genes in cytogenetic band chr16p13	C1QTNF8 C16orf96 MCRIP2 PKMYT1 MMP25 PIGQ ZSCAN10	6.97e-04	426	157	7	chr16p13
Cytoband	Ensembl 112 genes in cytogenetic band chr5q23	LVRN FTMT MARCHF3 CHSY3	7.23e-04	117	157	4	chr5q23
Cytoband	19p13.11	SLC35E1 ARRDC2 IL27RA	2.05e-03	73	157	3	19p13.11
Cytoband	20q13.32	ZNF831 APCDD1L	2.12e-03	20	157	2	20q13.32
GeneFamily	Fibronectin type III domain containing	BOC COL7A1 LRFN1 TSPOAP1 OBSCN PTPRJ PTPRS IL27RA	2.73e-06	160	99	8	555
GeneFamily	Blood group antigens\|CD molecules\|I-set domain containing\|Immunoglobulin like domain containing	BOC LRFN1 OBSCN LRIG2 PTPRS FGFR1	2.57e-04	161	99	6	593
GeneFamily	CD molecules\|Type I classical cadherins	CDH2 CDH4	2.94e-04	5	99	2	1185
Coexpression	MIKKELSEN_ES_ICP_WITH_H3K4ME3	TNK1 MICAL1 COL7A1 SETD1B CYP2D6 TSPOAP1 FAM83E CPT1B ARHGEF15 SLC2A10 ZMAT5 ZSCAN10 KCND1 HSPB6 INTS9 CTNND1 FAM149A	1.59e-06	728	155	17	M2004
Coexpression	MIKKELSEN_ES_ICP_WITH_H3K4ME3	TNK1 MICAL1 COL7A1 SETD1B CYP2D6 TSPOAP1 FAM83E CPT1B ARHGEF15 SLC2A10 ZMAT5 ZSCAN10 KCND1 HSPB6 INTS9 CTNND1 FAM149A	6.26e-06	807	155	17	MM855
Coexpression	GSE19888_ADENOSINE_A3R_ACT_VS_TCELL_MEMBRANES_ACT_AND_A3R_INH_PRETREAT_IN_MAST_CELL_DN	TNK1 CDC42BPG COL7A1 CYP2D6 SH3RF1 FREM2 ATRNL1 ARRDC2	2.54e-05	199	155	8	M7319
Coexpression	GSE25123_CTRL_VS_IL4_STIM_PPARG_KO_MACROPHAGE_UP	TNK1 COL5A1 ANK1 TFR2 PKMYT1 PIGQ ZMAT5 PTPRJ	2.64e-05	200	155	8	M7975
ToppCell	kidney_cells-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	BOC ARHGEF15 FAM111B SLC2A10 RADIL FGFR1 LTF CA4	2.37e-07	178	157	8	375156ba1c7b8592bf733c75f24968161f7cfa09
ToppCell	droplet-Lung-1m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l1\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	BOC COL5A1 PLEKHA4 KIFC2 ZNF786 CDH22 NDC1 FGFR1	3.05e-07	184	157	8	e33e2a887aafba7b6a31f00bb0dbe974b4359fd6
ToppCell	Control-Fibroblasts-Mesothelial_FB\|Control / group, cell type (main and fine annotations)	CYP1B1 SHISAL1 CDH22 ATRNL1 ADGRD2 LTF CDH2	6.39e-07	139	157	7	e769beb031b262dd92c9605b07dbf3c29fb82520
ToppCell	facs-Heart-RA-24m-Mesenchymal-atrial_myocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ANK1 OBSCN CPT1B ADAD2 FAM216B LTF STRC	1.45e-06	157	157	7	9021900d9b1a71210c9c414a9d165eaf399eb607
ToppCell	facs-Heart-RA-24m-Mesenchymal-atrial_cardiomyocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ANK1 OBSCN CPT1B ADAD2 FAM216B LTF STRC	1.45e-06	157	157	7	c8c627ca181856cd31dba4cf073c2be659a49dc1
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Fibroblasts-Pericyte_2\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CYP1B1 PLEKHA4 MCRIP2 HIVEP3 STRC CDH2 CDH4	1.51e-06	158	157	7	7f5426585d0d299d2b48e5fcb349950feffdef33
ToppCell	droplet-Liver-Npc-18m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CCDC9B SH3RF1 ARHGAP23 ARHGEF15 EVA1B CHST2 TRIM37	2.66e-06	172	157	7	a6fb1bde8d942c7b5caaf7bd14de0b7ce32fda55
ToppCell	Parenchymal-10x5prime-Epithelial-Epi_airway_ciliated-Deuterosomal\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	CCNP CCDC187 FAM216B RECQL4 PRR32 CDC20 HR	6.07e-06	195	157	7	e525b69145059b66417589601f7109af63730f3a
ToppCell	Bronchial-10x5prime-Epithelial-Epi_airway_basal-Dividing_Basal\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	C16orf96 FAM111B PKMYT1 ADAD2 RECQL4 LTF CDC20	6.49e-06	197	157	7	25bbe270d0897b9b1bd00d205f66efd1def81b99
ToppCell	Fibroblasts-CD34+_Fibroblasts\|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues	BOC CYP1B1 COL5A1 RARRES1 PTPRS HSPB6 FGFR1	6.93e-06	199	157	7	13ff7409e200a0b46cdb7924d15ef33639693622
ToppCell	distal-1-mesenchymal-Lipofibroblast\|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	BOC CYP1B1 RARRES1 ZNF469 PTPRS HSPB6 FGFR1	6.93e-06	199	157	7	a8293db3c42a8d30897858b49aae7acfc18663ba
ToppCell	distal-1-mesenchymal-Adventitial_Fibroblast\|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	CYP1B1 COL5A1 RARRES1 PTPRS MARCHF3 HSPB6 FGFR1	7.16e-06	200	157	7	738060ed65fa5473fdb39e686f7cdecc059ed92c
ToppCell	(5)_Fibroblast-H\|World / Lung cell shreds - cell class (v4) and cell subclass (v4)	CYP1B1 COL5A1 RARRES1 PLEKHA4 SYDE1 PTPRS HSPB6	7.16e-06	200	157	7	94e77a1082ade6fad93a37168e037af8aefe7ff4
ToppCell	LPS-IL1RA+antiTNF-Hematopoietic_Mast-Mast_cells-T-cells\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MMP25 PTPN7 ADAMTSL5 TMC8 WNT10A IL27RA	1.61e-05	151	157	6	b85a763459a0f019d1f9975d09b9f2247d62c9d3
ToppCell	frontal_cortex-Neuronal-glutamatergic_neuron-L6_CT\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	COL5A1 ISLR2 OBSCN EXTL1 SHISAL1 NXPH3	1.94e-05	156	157	6	fe383ce3a0c37f7343d7026cb51260a04d4c2829
ToppCell	LPS-antiTNF-Endothelial-Epi-like-Alv_Cap\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	POLRMT FAM83E KIFC2 TTLL12 NYNRIN CDH4	2.01e-05	157	157	6	abfd05ed993b80822739f47a735f154092a23632
ToppCell	facs-Large_Intestine-Distal-18m-Epithelial-Enterocyte_(Proximal)\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDZD7 CPT1B NFAM1 NAGS TESK2 PLD4	2.16e-05	159	157	6	709b57f992a29878cc899d760d144d36cb5cb280
ToppCell	PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_prolif\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	POLD1 FAM53C KIFC2 PTPN7 TMC8 IL27RA	2.16e-05	159	157	6	f7bccfeffa737f151417bf52ea45111b0957bce9
ToppCell	LPS-IL1RA+antiTNF-Lymphocytic_NKT-iNKT/MAIT-T-cells\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MARS2 CCDC137 ZNF831 PTPN7 CHFR LRRC56	2.23e-05	160	157	6	5c931e859acf67c1c8664941e0e44d195f8ba75b
ToppCell	(1)_Control_(PBS)-(4)_COL2.3+_osteoblasts\|World / Stress and Cell class	BOC COL5A1 PTPRS AVPI1 FGFR1 SEC23A	2.23e-05	160	157	6	ab769516f9f7798d1390ef215caf22a2d3d53e63
ToppCell	PND01-03-samps-Myeloid-Macrophage-CD163+_Macrophage\|PND01-03-samps / Age Group, Lineage, Cell class and subclass	RARRES1 CPT1B ZNF831 MCRIP2 NDC1 TESK2	2.23e-05	160	157	6	4480a7d6bd48d06b4e5196faac868f31ab7ed3ad
ToppCell	primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_CT\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	COL5A1 ISLR2 OBSCN ZNF831 SHISAL1 NXPH3	2.40e-05	162	157	6	58da6bc04cdac0002b0e6a751c96ff95e1a7f70f
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar-Mes-like\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	UBQLN4 MCRIP2 KIAA1614 MMP25 CDC20 FUT5	2.48e-05	163	157	6	360cd65decda24853124f33a174f5224d7f3ce23
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar-Mes-like-AT1_Progenitor\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	UBQLN4 MCRIP2 KIAA1614 MMP25 CDC20 FUT5	2.48e-05	163	157	6	b59d9b4f7c9f4e5e2c7783a49a96729dae3a81e5
ToppCell	facs-Marrow-T_cells-18m-Lymphocytic-late_pro_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SH3RF1 FAM83E SYDE1 IGLL1 CDC20 FAM149A	2.66e-05	165	157	6	0edd56e8d14eaeced9882dd9206ea93e8f402e8d
ToppCell	facs-Marrow-T_cells-18m-Lymphocytic-late_pro-B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SH3RF1 FAM83E SYDE1 IGLL1 CDC20 FAM149A	2.66e-05	165	157	6	fa3aadfff6fb1e7f142db333c60c2cba02b17e6c
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ARHGAP23 ZNF831 HIVEP3 CHSY3 ADGRD2 HR	3.14e-05	170	157	6	6035c92cd39c5ac54e7ec57d94888ee19f574639
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_medulla\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ARHGAP23 ZNF831 HIVEP3 CHSY3 ADGRD2 HR	3.14e-05	170	157	6	c8c42eda44b61440c96b202e7f54650046eb95d3
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_medulla-lymphatic_endothelial_cell_of_renal_medulla\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ARHGAP23 ZNF831 HIVEP3 CHSY3 ADGRD2 HR	3.14e-05	170	157	6	dcc64b73134e89ae37990d4878813b86ce91dae9
ToppCell	kidney_cells-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell_prolif\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SYDE1 FAM111B PKMYT1 EVA1B VSIG10L NXPH3	3.35e-05	172	157	6	94093d356b0252b440deda4e1b0ac332b31513f6
ToppCell	(0)_Normal/No_Treatment-(4)_COL2.3+_osteoblasts\|(0)_Normal/No_Treatment / Stress and Cell class	BOC COL5A1 MAGED1 PTPRS FGFR1 SEC23A	3.46e-05	173	157	6	c2a0f674681836b5a868c13f67caa7d555ef6519
ToppCell	5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	FAM111B SYNGAP1 NYNRIN HSPB6 LTF AGBL2	3.58e-05	174	157	6	e2243f1e48e3275753a2b3a69d06eefce69a8ded
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CDC42BPG COL7A1 ARHGAP23 OBSCN PKMYT1 KCND1	3.58e-05	174	157	6	207aa0118633cbe9a65839bbb1bb3ba9f8118ad2
ToppCell	E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_prolif\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	RARRES1 PLEKHA4 FREM2 ADAMTSL5 ACOT11 NXPH3	3.58e-05	174	157	6	4da79da7a09ee1e345102c5331675ebcdbe56171
ToppCell	droplet-Liver-Npc-18m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SH3RF1 ARHGAP23 ARHGEF15 EVA1B CHST2 TRIM37	3.81e-05	176	157	6	3494ffa8555e6edf4b1250e10434bae9b73ec845
ToppCell	droplet-Liver-Npc-18m-Endothelial\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SH3RF1 ARHGAP23 ARHGEF15 EVA1B CHST2 TRIM37	3.81e-05	176	157	6	d43f6b7828b98e1dab7b726a5f99499d65a7db80
ToppCell	5'-Airway_Nasal-Mesenchymal-Fibroblastic\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL5A1 COL7A1 EXTL1 ZNF469 FGFR1 CDH2	4.32e-05	180	157	6	935c091bbcd6d10b81dc4731779e5bd98205c99f
ToppCell	5'-Airway_Nasal-Mesenchymal\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL5A1 COL7A1 EXTL1 ZNF469 FGFR1 CDH2	4.32e-05	180	157	6	3dd384b7f3d9582b8fec9fe05100e466e6218b76
ToppCell	5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL5A1 COL7A1 EXTL1 ZNF469 FGFR1 CDH2	4.74e-05	183	157	6	803376f5260de83c48d4f7301278d078a32b3e6e
ToppCell	5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL5A1 COL7A1 EXTL1 ZNF469 FGFR1 CDH2	4.74e-05	183	157	6	6d98973098c6d20c5305bce6a83a549a7d8dbfba
ToppCell	5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL5A1 COL7A1 EXTL1 ZNF469 FGFR1 CDH2	4.74e-05	183	157	6	cc7f5a17b40e8d901885174922e5fa8877643071
ToppCell	367C-Lymphocytic-NK_cells-Proliferating_NK_cell\|NK_cells / Donor, Lineage, Cell class and subclass (all cells)	PPRC1 POLD1 GAB2 PKMYT1 CDC20 GDPGP1	4.74e-05	183	157	6	a716b446c2bf5aa294b8f580aa845098fae76354
ToppCell	(2)_5-FU-(4)_COL2.3+_osteoblasts\|World / Stress and Cell class	BOC COL5A1 PTPRS AVPI1 FGFR1 SEC23A	4.88e-05	184	157	6	684d05340a3dfb8aa08b881516a37f9627a10448
ToppCell	droplet-Lung-21m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SHANK1 CYP1B1 COL5A1 GDF6 GPR88 FGFR1	5.03e-05	185	157	6	1b990e3089772be2b38c6d7ea0d1bf22461ae3ea
ToppCell	droplet-Spleen-nan-21m-Hematologic-megakaryocyte-erythroid_progenitor_cell\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL5A1 ARHGAP23 MCRIP2 TFR2 TTLL12 CDC20	5.03e-05	185	157	6	239cc5184825b3cc98638d4aec0a1de8e508d76c
ToppCell	droplet-Limb_Muscle-Pre-Sort-18m-Macroglial-unknown\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL7A1 PLEKHA4 EXTL1 GPR88 KIFC2 FREM2	5.03e-05	185	157	6	11c147f3f5570c4761d2bcff3bad28146b4a5861
ToppCell	Adult-Mesenchymal-matrix_fibroblast_2_cell-D231\|Adult / Lineage, Cell type, age group and donor	BOC CYP1B1 COL5A1 RARRES1 PTPRS FGFR1	5.03e-05	185	157	6	fb6bd7e849ecf4ed9cd9c4e2a946a2d12d62f804
ToppCell	droplet-Lung-1m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	BOC CYP1B1 COL5A1 ISLR2 FGFR1 FAM149A	5.34e-05	187	157	6	ed7ab4cf4629d96dad5c74d536fc428d0a8d4eb9
ToppCell	10x5'-lymph-node_spleen-Hematopoietic_Erythro-Mega-Erythrocytic_early\|lymph-node_spleen / Manually curated celltypes from each tissue	ANK1 TFR2 SLC2A10 HSPB6 IGLL1 CDC20	5.34e-05	187	157	6	61d346c9873c2edb3ce224a0c063c54d9a68309e
ToppCell	facs-Heart-Unknown\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ANK1 OBSCN CPT1B MCRIP2 HSPB6 CDH2	5.34e-05	187	157	6	362e56426a568423a81e8a30e3ecf99b76135843
ToppCell	facs-Heart-Unknown-3m\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ANK1 OBSCN CPT1B MCRIP2 HSPB6 CDH2	5.34e-05	187	157	6	c004567767b89f3d89f5c7b28d952f3445957e1e
ToppCell	5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	LVRN BOC COL5A1 PTPRS HSPB6 FGFR1	5.67e-05	189	157	6	d531399749409d614adca13d181830c6e3287508
ToppCell	Control-CD4+_T_activated\|Control / Disease condition and Cell class	EXTL1 ARHGEF15 ATRNL1 PRR34 CDH4	5.70e-05	116	157	5	e3d1a90a229f5697b2b715574bb96790a435f73b
ToppCell	Adult-Mesenchymal-matrix_fibroblast_2_cell-D175\|Adult / Lineage, Cell type, age group and donor	LVRN BOC COL5A1 RARRES1 PTPRS MARCHF3	5.83e-05	190	157	6	7dcca3469f3a3b70db0420cb94f7765f39492f06
ToppCell	10x5'v1-week_17-19-Mesenchymal_myocytic-stroma\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	BOC TMEM30B SLC2A10 FGFR1 CDH2 NXPH3	5.83e-05	190	157	6	81f8f2cddf4c51b879f315260cd1fca80355a371
ToppCell	10x5'v1-week_17-19-Mesenchymal_myocytic-stroma-muscle\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	BOC TMEM30B SLC2A10 FGFR1 CDH2 NXPH3	5.83e-05	190	157	6	20106e5213f6a7560554b8b4f84b23c5554ba975
ToppCell	10x5'v1-week_17-19-Mesenchymal_myocytic\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	BOC TMEM30B SLC2A10 FGFR1 CDH2 NXPH3	5.83e-05	190	157	6	877b544decf302e0d41be23dffa1861f79c70914
ToppCell	PBMC-Control-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	EXTL1 ARHGEF15 ATRNL1 PRR34 CDH4	6.18e-05	118	157	5	f76fc6db7368a1e8e5e4f8535fc3dc78afe13b9b
ToppCell	PBMC-Control-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	EXTL1 ARHGEF15 ATRNL1 PRR34 CDH4	6.18e-05	118	157	5	0dcac16eea8e7978de370a815da9a0cdd212598e
ToppCell	PBMC-Control-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	EXTL1 ARHGEF15 ATRNL1 PRR34 CDH4	6.18e-05	118	157	5	7da3957d102e9f9825fc2609d6d0bd9ca6a3fba4
ToppCell	PBMC-Control-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	EXTL1 ARHGEF15 ATRNL1 PRR34 CDH4	6.18e-05	118	157	5	c5c6724e0e526d7c2fc8cabff4a112a900ec997f
ToppCell	droplet-Spleen-SPLEEN-1m-Hematologic-megakaryocyte-erythroid_progenitor_cell\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL5A1 ANK1 NAGS TFR2 TTLL12 RECQL4	6.18e-05	192	157	6	a94f47a664a3c9d1b0250269674453309ab4bf95
ToppCell	Adult-Mesenchymal-matrix_fibroblast_2_cell\|Adult / Lineage, Cell type, age group and donor	LVRN BOC COL5A1 RARRES1 PTPRS MARCHF3	6.18e-05	192	157	6	d21f0f577156f17c899b08871046a26b88aea011
ToppCell	TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-10\|TCGA-Colorectal / Sample_Type by Project: Shred V9	BOC CYP1B1 GDF6 ARHGEF15 CHSY3 FGFR1	6.36e-05	193	157	6	194e7fa00a50cc4e026987b715323d125d79594e
ToppCell	Fetal_brain-fetalBrain_Zhong_nature-GW19-OPC_related\|GW19 / Sample Type, Dataset, Time_group, and Cell type.	COL7A1 CCDC9B POLD1 GDF6 FAM120AOS ADM5	6.36e-05	193	157	6	80ae4d11e373e54ead919294786e0a8cbd11ea8a
ToppCell	Fetal_brain-fetalBrain_Zhong_nature-GW19-OPC_related-OPC\|GW19 / Sample Type, Dataset, Time_group, and Cell type.	COL7A1 CCDC9B POLD1 GDF6 FAM120AOS ADM5	6.36e-05	193	157	6	5c3b4cc1ca8439ac59ba00253903b9774dc048f8
ToppCell	Control-Lymphoid_T/NK-CD4+_T_activated\|Control / Disease group, lineage and cell class	EXTL1 ARHGEF15 ATRNL1 PRR34 CDH4	6.43e-05	119	157	5	d7352d0dafbb664619b7a1e3cd07b159fdfec197
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	POLD1 FAM111B PKMYT1 NDC1 ATRNL1 RECQL4	6.55e-05	194	157	6	590a9d4f054e6a3685daf752c9354650fcc7d18a
ToppCell	10x5'v1-week_14-16-Mesenchymal_osteo-stroma-osteoblast\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	BOC COL5A1 RARRES1 PTPRS FGFR1 CDH2	6.55e-05	194	157	6	292ce9021678534c9eedb367b9772a9d976208a8
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	COL5A1 RARRES1 PTPRS HSPB6 FGFR1 HR	6.74e-05	195	157	6	ff0aa455e9844a6d7ae57ff59fb6cea825cf1fc2
ToppCell	TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-4\|TCGA-Prostate / Sample_Type by Project: Shred V9	ARHGAP23 KIAA1614 SYDE1 ZNF469 NYNRIN FGFR1	6.74e-05	195	157	6	5562665dd3beb70e2358aa32611a337bef5731c1
ToppCell	10x5'v1-week_17-19-Mesenchymal_osteo-stroma-osteoblast\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	BOC COL5A1 RARRES1 PTPRS FGFR1 CDH2	6.93e-05	196	157	6	d5ed41fa111750e6b363c04cccc40a47dd774852
ToppCell	myeloid-pro-pDC\|myeloid / Lineage and Cell class	MAGED1 FAM111B PTPRS IGLL1 CDC20 PLD4	6.93e-05	196	157	6	70daf4fabb68aecc5cc9f03d6f6495dd29b74a16
ToppCell	10x3'2.3-week_14-16-Mesenchymal_osteo-stroma-osteoblast\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	BOC COL5A1 RARRES1 PTPRS FGFR1 CDH2	6.93e-05	196	157	6	760885dc608c82768fe0decd63ed9fda8315f453
ToppCell	PND07-28-samps-Mesenchymal-Matrix_fibroblast-mesenchymal_C\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	PPRC1 CHRM4 SLC2A10 CDH22 ADAMTSL5	6.96e-05	121	157	5	176de42c088988fe1a7838f96add26ee8a30e543
ToppCell	3'-GW_trimst-1-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	BOC COL5A1 ZNF469 HSPB6 FGFR1 CHST2	7.33e-05	198	157	6	9541d68a1a6247dbd7161a62644eea6527c2c8ff
ToppCell	Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Mesothelial-1-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	RARRES1 PLEKHA4 ADAMTSL5 APCDD1L LRRC56 FGFR1	7.33e-05	198	157	6	2dc0510846cbc296a300b8465e7be9b39f479852
ToppCell	distal-mesenchymal-Adventitial_Fibroblast-2\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	BOC RARRES1 PTPRS ATRNL1 HSPB6 FGFR1	7.33e-05	198	157	6	bfd720e2dae3b6b3dc2bf8b2096c554fd456e756
ToppCell	Parenchyma_Control_(B.)-Stromal-TX-Mesothelial-1\|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type	RARRES1 PLEKHA4 ADAMTSL5 APCDD1L LRRC56 FGFR1	7.33e-05	198	157	6	eb7e674d08a7aeb554c1e4797338280581b79989
ToppCell	Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Mesothelial-1\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	RARRES1 PLEKHA4 ADAMTSL5 APCDD1L LRRC56 FGFR1	7.33e-05	198	157	6	364de83e30d842123fb92367f54b4bea57a47c84
ToppCell	(0)_NK_Dividing\|World / Lung cell shreds - cell class (v4) and cell subclass (v4)	POLD1 FAM111B PKMYT1 RECQL4 CHST2 CDC20	7.33e-05	198	157	6	5ebb4965b723302152b42bfaf48bb77a57dd02c5
ToppCell	Sigmoid-T_cell-Tfh\|Sigmoid / Region, Cell class and subclass	CDC42BPG TMEM30B PDZD7 FAM111B ADGRD2 LTF	7.53e-05	199	157	6	fa9404a021a015d1d571c324780b6eef2da47c4c
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	BOC COL5A1 RARRES1 PTPRS MARCHF3 FGFR1	7.53e-05	199	157	6	f835e7ffe976843b0edbf695762d463da85793f3
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_1-AF2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	BOC COL5A1 RARRES1 PTPRS MARCHF3 FGFR1	7.53e-05	199	157	6	993fa050a095017135a6e723c77cd38b9d782e58
ToppCell	Sigmoid-(1)_T_cell-(16)_Tfh\|Sigmoid / shred on region, Cell_type, and subtype	CDC42BPG TMEM30B PDZD7 FAM111B ADGRD2 LTF	7.53e-05	199	157	6	a61bf52d2d359746433623ee00337124f1f84f61
ToppCell	TCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma\|TCGA-Bladder / Sample_Type by Project: Shred V9	CCDC137 POLD1 PKMYT1 RECQL4 CDC20 MFSD3	7.53e-05	199	157	6	8ee3dbc0a92de5f3865e5484970ae2aab7d1a956
ToppCell	TCGA-Bladder-Primary_Tumor\|TCGA-Bladder / Sample_Type by Project: Shred V9	CCDC137 POLD1 PKMYT1 RECQL4 CDC20 MFSD3	7.53e-05	199	157	6	c403e28def2e14f5931cd73b4fb9a4078c0439f8
ToppCell	Biopsy_IPF-Mesenchymal-PLIN2+_Fibroblasts\|Biopsy_IPF / Sample group, Lineage and Cell type	BOC CYP1B1 COL5A1 MARCHF3 HSPB6 FGFR1	7.75e-05	200	157	6	2c5626ea8fb4b702d4560117e53edf6cfcf1971e
ToppCell	cellseq-Mesenchymal-Fibroblastic-Fibroblastic_1-AF2\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	BOC CYP1B1 COL5A1 RARRES1 HSPB6 FGFR1	7.75e-05	200	157	6	28e5354008adf97b17333f17f8cbef930db6729a
ToppCell	Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_adventitial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	BOC COL5A1 RARRES1 PLEKHA4 MARCHF3 FGFR1	7.75e-05	200	157	6	ad3fdcef895400f929f2ae12ff9bd85fd46adb3a
ToppCell	390C-Fibroblasts-Fibroblast-H-\|390C / Donor, Lineage, Cell class and subclass (all cells)	CYP1B1 COL5A1 RARRES1 PLEKHA4 PTPRS HSPB6	7.75e-05	200	157	6	ec7d6a08e34bcad5b3bbff56ebef96ae17e4cefd
ToppCell	normal_Lung-Fibroblasts\|normal_Lung / Location, Cell class and cell subclass	BOC COL5A1 RARRES1 PTPRS HSPB6 FGFR1	7.75e-05	200	157	6	803cf7f1382d07220249029cd220233232027689
ToppCell	Parenchymal-10x5prime-Stromal-Peri/Epineurial_-NAF_epineurial\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	CYP1B1 RARRES1 PLEKHA4 KIAA1614 NYNRIN VSIG10L	7.75e-05	200	157	6	36de49593cf6ff1c9229fcceb150c1d68658a360
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW19-Neuroepithelial-Proteoglycan-expressing_cell\|GW19 / Sample Type, Dataset, Time_group, and Cell type.	ANK1 FAM83E TFR2 ADAMTSL5 ARRDC2 CA4	7.75e-05	200	157	6	aafe594c88710f8c53d59667cdac5035e08f5511
ToppCell	medial-mesenchymal-Adventitial_Fibroblast\|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	BOC CYP1B1 RARRES1 MARCHF3 HSPB6 FGFR1	7.75e-05	200	157	6	87a5a0c252c08ba10316c21f6a9d5244c4d98c74
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW19-Neuroepithelial\|GW19 / Sample Type, Dataset, Time_group, and Cell type.	ANK1 FAM83E TFR2 ADAMTSL5 ARRDC2 CA4	7.75e-05	200	157	6	a6f0f5f644b7262878b0b9d4d90ee407c4124dd9
ToppCell	390C-Fibroblasts-Fibroblast-H\|390C / Donor, Lineage, Cell class and subclass (all cells)	CYP1B1 COL5A1 RARRES1 PLEKHA4 PTPRS HSPB6	7.75e-05	200	157	6	671e731977c58a0c44c36b56422085d93d999aad
ToppCell	medial-2-mesenchymal-Adventitial_Fibroblast\|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	BOC CYP1B1 RARRES1 MARCHF3 HSPB6 FGFR1	7.75e-05	200	157	6	6ccf44f10d2cee5f48b8f05bd9a1b94057184d56
ToppCell	normal_Lung-Fibroblasts-COL14A1+_matrix_FBs\|normal_Lung / Location, Cell class and cell subclass	BOC COL5A1 RARRES1 PTPRS HSPB6 FGFR1	7.75e-05	200	157	6	ee3d06865a6300e1279edf6664320b71647f5efb
ToppCell	medial-mesenchymal-Adventitial_Fibroblast-2\|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	BOC CYP1B1 RARRES1 MARCHF3 HSPB6 FGFR1	7.75e-05	200	157	6	5ee1318a74ca28a81bd81c20c611de84c17636b0
Disease	CCL2 measurement	FCRL6 HIVEP3 RADIL CDH4 FAM149A	4.59e-04	126	149	5	EFO_0004749
Disease	Tremor, Neonatal	CYP2D6 CHRM4	8.91e-04	9	149	2	C0235843
Disease	Tremor, Perioral	CYP2D6 CHRM4	8.91e-04	9	149	2	C0235078
Disease	Nerve Tremors	CYP2D6 CHRM4	8.91e-04	9	149	2	C0235083
Disease	Tremor, Limb	CYP2D6 CHRM4	8.91e-04	9	149	2	C0235081
Disease	Tremor, Muscle	CYP2D6 CHRM4	8.91e-04	9	149	2	C0235082
Disease	Senile Tremor	CYP2D6 CHRM4	8.91e-04	9	149	2	C0149840
Disease	Pill Rolling Tremor	CYP2D6 CHRM4	8.91e-04	9	149	2	C0751564
Disease	Tremor, Semirhythmic	CYP2D6 CHRM4	8.91e-04	9	149	2	C0751565
Disease	Action Tremor	CYP2D6 CHRM4	8.91e-04	9	149	2	C0234376
Disease	Passive Tremor	CYP2D6 CHRM4	8.91e-04	9	149	2	C0234377
Disease	Static Tremor	CYP2D6 CHRM4	8.91e-04	9	149	2	C0234378
Disease	Resting Tremor	CYP2D6 CHRM4	8.91e-04	9	149	2	C0234379
Disease	Intermittent Tremor	CYP2D6 CHRM4	8.91e-04	9	149	2	C0234372
Disease	Fine Tremor	CYP2D6 CHRM4	8.91e-04	9	149	2	C0234373
Disease	Coarse Tremor	CYP2D6 CHRM4	8.91e-04	9	149	2	C0234374
Disease	Massive Tremor	CYP2D6 CHRM4	8.91e-04	9	149	2	C0234375
Disease	Persistent Tremor	CYP2D6 CHRM4	8.91e-04	9	149	2	C0234370
Disease	Continuous Tremor	CYP2D6 CHRM4	8.91e-04	9	149	2	C0234371
Disease	Darkness Tremor	CYP2D6 CHRM4	8.91e-04	9	149	2	C0234381
Disease	Involuntary Quiver	CYP2D6 CHRM4	8.91e-04	9	149	2	C1527384
Disease	Saturnine Tremor	CYP2D6 CHRM4	8.91e-04	9	149	2	C0040827
Disease	Colorectal Carcinoma	SHANK1 BOC CYP1B1 COL7A1 CCDC9B POLD1 OBSCN HIVEP3 CDH22 PTPRS HR	9.10e-04	702	149	11	C0009402
Disease	reticulocyte measurement	ANK1 PLEKHA4 PPP1R15A ARHGEF15 GAB2 TFR2 PIGQ ZNF469 PTPRJ MARCHF3 TESK2 TMC8 ADGRD2 CTNND1	9.32e-04	1053	149	14	EFO_0010700
Disease	obsolete_red blood cell distribution width	LVRN MARS2 SETD1B ANK1 ARHGAP23 PPP1R15A C1orf53 TFR2 PIGQ TMC8 CHSY3 FGFR1 ADGRD2 CHST2 NUTM2F IL27	1.32e-03	1347	149	16	EFO_0005192
Disease	Tremor	CYP2D6 CHRM4	1.35e-03	11	149	2	C0040822
Disease	Oligodontia	WNT10A FGFR1	1.62e-03	12	149	2	C4082304
Disease	Hypodontia	WNT10A FGFR1	2.21e-03	14	149	2	C0020608
Disease	5-methyluridine (ribothymidine) measurement	CPT1B PTPRS	2.21e-03	14	149	2	EFO_0020013
Disease	cleft lip (is_implicated_in)	GDF6 FGFR1	2.55e-03	15	149	2	DOID:9296 (is_implicated_in)
Disease	Hepatomegaly	A1BG CYP1B1 TRIM37	2.59e-03	54	149	3	C0019209
Disease	nervousness	PTPRJ AGBL2	2.90e-03	16	149	2	NCIT_C74532
Disease	Necrotizing Enterocolitis	SNAI3 LTF	3.28e-03	17	149	2	C0520459
Disease	nevus count	CYP1B1 FMN1	3.67e-03	18	149	2	EFO_0004632
Disease	serum carcinoembryonic antigen measurement	FAM83E FUT5	4.53e-03	20	149	2	EFO_0005760
Disease	Infiltrating duct carcinoma of female breast	TESK2 FGFR1	4.99e-03	21	149	2	C3165106

Protein segments in the cluster

Peptide	Gene	Start	Entry
PPLQPRALNPASRWS	CHRM4	326	P08173
PLGKQRPAPWPGLRS	CCDC137	31	Q6PK04
AIRGRSKINPPPWAP	LINC01547	146	P58512
ASLQISPQPRPWRPL	ADAD2	21	Q8NCV1
SPQPRPWRPLPAQAQ	ADAD2	26	Q8NCV1
LDAPIPNAPPARWQR	CDC20	16	Q12834
EGQPRAPGPLQLWAP	ADM5	66	C9JUS6
APGPLQLWAPPVARG	ADM5	71	C9JUS6
WKERPPQVLGPQQRP	CCDC187	131	A0A096LP49
GLRIPLPPSWTDNPR	ANK1	1146	P16157
LWNVPQLPFIRVPPS	FAM216B	11	Q8N7L0
PSTAILPPRLNGPWI	APCDD1L	46	Q8NCL9
PPPWQAPIEARGRKQ	AVPI1	11	Q5T686
PWGFPLRPTNPSEIR	ABHD4	171	Q8TB40
LRPTNPSEIRAPPAW	ABHD4	176	Q8TB40
QPQLLPWIRPQPGDG	ACOT11	331	Q8WXI4
PRPPGPRNTLWQELP	ARHGEF15	386	O94989
NWRPPGPWDQLRLPP	LVRN	86	Q6Q4G3
SRGQRILSIPIWPPN	ANGEL2	386	Q5VTE6
PIVRRWAPRPSPLQS	CCNP	16	Q9H8S5
WQGRALRIPPVGPSI	ARRDC2	256	Q8TBH0
LAGPRPVPWASLLPV	C17orf113	346	A0A1B0GUU1
PTPRLQWQLQIPGGT	ISLR2	266	Q6UXK2
WEAPAPQRPLTRPAL	RAVER1	546	Q8IY67
LRNQRETLPLPPSWP	TSPOAP1	281	O95153
DRTPGRLQAVWPPPK	FMN1	691	Q68DA7
LPLVQSPRLSNLPGW	INTS9	41	Q9NV88
PLTRWALQRQPPSPK	PTPN7	81	P35236
GPGPWQRRIRELQAP	CDC42BPG	1211	Q6DT37
LRGAPWAQAPPGRQP	RADIL	871	Q96JH8
VDGPPPRPQLRATWS	A1BG	396	P04217
LGPLRFTLPQPAEPW	CES1P1	61	Q9UKY3
LNQAAGRWPAPIPLL	MMP25	536	Q9NPA2
PPRSPGLRWALPLLL	PTPRJ	11	Q12913
AVGWLPLAQQPLPPA	KCND1	16	Q9NSA2
GLVLLLPPWAPRPGA	GPR88	171	Q9GZN0
PVQPSWLRRASAPLP	HSPB6	6	O14558
WLPSGRAALPPAAPL	LRP11	31	Q86VZ4
PPDWQNLRPSPNLRP	MAGED1	436	Q9Y5V3
VWAALPRNPLQPGPG	FAM149A	136	A5PLN7
PGPPLPARGHALLRW	SLC2A10	396	O95528
NSVLIRWPAQRPVPG	LRFN1	436	Q9P244
RAPPDGILPWELNSP	FREM2	3091	Q5SZK8
APQPPRVWGVQLQGP	KIAA1614	66	Q5VZ46
RSWRKAGPLPSQIPP	FCRL6	331	Q6DN72
RGPAPVAPAFLPLWL	CCDC9B	16	Q6ZUT6
RPRLPPPGALLWLQE	HR	836	O43593
PPGLALRPLEPQLWA	HR	976	O43593
PPPQDPLGRRRWLSR	FAM157A	246	C9JC47
VAPRPLRPNWLLTEP	PDZD7	741	Q9H5P4
NWVRLPPGNLSALLP	IL27RA	366	Q6UWB1
PLVGPTLWRLQDAPP	IL27RA	416	Q6UWB1
WLEQPFPGAVPSLRP	MBOAT7	176	Q96N66
PPPRKGSGWRAQLQP	MICAL1	186	Q8TDZ2
IQWPRNAPGIPDALP	GDPGP1	41	Q6ZNW5
GRRLSTAWSQPQPPP	NAGS	46	Q8N159
PQGRQSPWPLRSLTQ	POM121L12	46	Q8N7R1
AWAAPALRRLPQQPP	MFSD3	181	Q96ES6
GWPLRQPQPRGVEPQ	ADAMTSL5	326	Q6ZMM2
VLLRWLPPVPAERNG	PTPRS	946	Q13332
GIQQRLALPVWRPPD	OBSCN	6001	Q5VST9
RPQPPNWGHLPDQLR	OVOL3	11	O00110
RPPTWGQVQPKDVPR	PLD4	56	Q96BZ4
NPVTQAPLPPGWEQR	ITCH	321	Q96J02
PPPPQDPLGRRRWLS	FAM157B	246	P0CG42
PPPQPWGRLLRLGAE	CHFR	11	Q96EP1
ISWAPRPRPRGPAQR	EVA1B	51	Q9NVM1
PGPNLRQRWPLLLLG	IGLL1	16	P15814
VRGNPPPSVLWLRNA	BOC	346	Q9BWV1
APGRPLPWALPALLG	CA4	286	P22748
PLWDLGVLRPTQPQP	C16orf96	406	A6NNT2
PATEFGSLWPRPLQP	C16orf96	426	A6NNT2
ARPSPTLPEQAQPWG	FGFR1	21	P11362
RQRWAARYPPGPLPL	CYP2D6	26	P10635
VWGFPRPPGRPQLSL	IL27	26	Q8NEV9
QGTAPPPNWRRPVYE	TMEM30B	221	Q3MIR4
WVIPPINVPENSRGP	CDH4	171	P55283
WRGLSSLQPPPPRFK	AGBL2	106	Q5U5Z8
RQPSAAPPPAPLWVR	C1orf53	16	Q5VUE5
APPPAPLWVRAGFRQ	C1orf53	21	Q5VUE5
TPQPAAPGVWRARPA	ATRNL1	11	Q5VV63
LLLWAPPPSRAAQPA	COL5A1	26	P20908
LLLPVGAWPGLPRRP	C1QTNF8	11	P60827
QAPVWRRSAPAQPPA	FRMD6-AS1	76	P0C7T7
RGPPGLAWPPVHRTL	FAM166B	46	A8MTA8
PWPLSSPGPRLVFNR	MCRIP2	56	Q9BUT9
PRPLVEWLRNPGPQH	MARCHF3	126	Q86UD3
AQVPRWKPQARAPQP	MAN2B1	581	O00754
RAPQPIPRRSWSPAL	MAN2B1	591	O00754
AVEPPWPLNRAPRRA	ATAT1	246	Q5SQI0
WNGTRPSLKAPPARP	KHDRBS1	416	Q07666
ILSWRPLRGPGQEVP	COL7A1	986	Q02388
QLRSAPPGPFAWPLI	CYP1B1	46	Q16678
LPPPPTLLGRLWAAG	CDH22	26	Q9UJ99
EGVQASPWRPRPVLP	C1orf127	321	Q8N9H9
AFPPGLWRQISPQPS	FAM111B	556	Q6SJ93
PELPWRPRGLRNLPR	FAM53C	256	Q9NYF3
LGAPEALREQPWPLP	POLRMT	556	O00411
DPRWLRPTPPALDPQ	POLD1	76	P28340
RPRWGQSPPPQQRSD	PPRC1	231	Q5VV67
WVIPPINLPENSRGP	CDH2	161	P19022
DSLRKGGPPPPNWRQ	CTNND1	351	O60716
LLLHWGPGPPIRAPQ	KIFC2	256	Q96AC6
LPSPQPAPRRAPWTL	MAP3K11	791	Q16584
GKPNPALAPPTRLQW	CPT1B	506	Q92523
RWAPGRPLDPRQIAP	FTMT	31	Q8N4E7
WARLRNPPLAPIPAL	PPP1R15A	616	O75807
QGPIPWFLPESRSLP	PPEF2	341	O14830
PFWQRPLGPIQLKLP	NYNRIN	391	Q9P2P1
WGILGQPPNRPNHSP	NXPH3	76	O95157
VAPIVSPGNARPWPQ	NUTM2F	166	A1L443
AETPRWGSPQQRPPI	GAB2	361	Q9UQC2
SANLPPPTRPQGQRW	FUT5	131	Q11128
LRLFRQAPSAPWGPP	GDF6	166	Q6KF10
LLQSWPDPRLPRQSP	SYDE1	596	Q6ZW31
IENLWGLQPRPPASL	TRIM37	631	O94972
LRPFLNWTGPPEPIE	LTF	151	P02788
PWGGALPLPPAHRLR	FAM83E	426	Q2M2I3
RPWPFSLLVRGGPLP	LRRC56	291	Q8IYG6
PLDWGPQRQTLSRPP	PLEKHA4	281	Q9H4M7
TLQAGPALGRRPWPL	RECQL4	116	O94761
RPPGLPAAPWLLLGV	NFAM1	16	Q8NET5
LQPRGAHLPPPQLWL	PIGQ	516	Q9BRB3
PQLWLPPQALLGRPV	PIGQ	526	Q9BRB3
APGSWPRVLLVPRSP	PRR34	61	Q9NV39
PGPRPARIPGLTLTW	FAM120AOS	96	Q5T036
PLPGLSHRQGWPRPL	PHF12	571	Q96QT6
PRRWGNPARAPRPGQ	SHISAL1	146	Q3SXP7
NQWPSEAIPPGPRGR	SETD1B	1611	Q9UPS6
EPWGQPQVPLRPSVN	PRR32	46	B1ATL7
AGLPPLLRAWRVPPA	SLC35E1	71	Q96K37
LLRAWRVPPAPPVSG	SLC35E1	76	Q96K37
PRPRPGASQGWPRWL	EXTL1	36	Q92935
LWGPPRGFRPEQILQ	STRC	1516	Q7RTU9
ELQRDPWPVPQGKRP	SEC23A	246	Q15436
PRVQSWSPPVRGIPQ	SH3RF1	121	Q7Z6J0
PPRLALGPQPSLRGW	SHANK1	1036	Q9Y566
PLLVLPTRWSPTLGP	SNAI3	116	Q3KNW1
RTSLWRQQQPPAPAP	SREBF1	981	P36956
PVWVGQREAPLRRPP	ADGRD2	96	Q7Z7M1
SPWQQPPPLQQRRRG	CHSY3	101	Q70JA7
APAAAPRALLPQWPR	CHST2	21	Q9Y4C5
PPALRLRALAWPQPR	PAK6-AS1	126	Q8N910
LLWRQPVVEPPPFSG	TTLL8	581	A6PVC2
LLGSFPRPPAPQGRW	nan	121	Q96NJ1
PRAAQPAEPGQWRLP	ZSCAN10	131	Q96SZ4
QWRLPPSSKQPLSPG	ZSCAN10	141	Q96SZ4
VWLRPPDPGPTLNLT	TMC8	136	Q8IU68
WPLLPALLGPPRALS	TMEM143	31	Q96AN5
NPRVTLAPPWNGLAP	SYNGAP1	1306	Q96PV0
LFPPRTPGWHQLQPR	PKMYT1	66	Q99640
LPARLPPGLRWLPAD	SLC27A5	76	Q9Y2P5
SPNPWPSRLPRGGLQ	STPG3	271	Q8N7X2
SPRRPFPWQGPRTLL	ARHGAP23	31	Q9P227
PRPPQGRRAAQSWSP	HIVEP3	2316	Q5T1R4
PLQRWLRGNPQAITP	MARS2	221	Q96GW9
PEGPPWLPRTFNLRT	TTLL12	381	Q14166
GQRLCLPQSAPLPWP	ZNF469	471	Q96JG9
PGPRNLDLPGLWDVP	ZNF786	166	Q8N393
GTPQRVLRPVVWSPP	nan	11	Q8N9G6
IPWNTGTPQRVLPPV	nan	6	A8MUA0
SPQPSQPSRERLPWP	TNK1	546	Q13470
SRPPRRPWAGILILQ	nan	96	Q6ZS52
VGWPPVQELPPSLRA	ZMAT5	141	Q9UDW3
PILLSRPGWLPQPSS	ZNF295-AS1	86	Q8N0V1
RSAVVPLPPRNPGTW	VSIG10L	731	Q86VR7
PLPPRNPGTWTFRIL	VSIG10L	736	Q86VR7
RLRPQPQPRPALWVL	WNT10A	11	Q9GZT5
WSRTQKPLSPRPGPA	ZNF831	526	Q5JPB2
PLAPPIRRWRSLPGS	TESK2	446	Q96S53
MQPRRQRLPAPWSGP	RARRES1	1	P49788
LRTENREPLPNPWSP	UBQLN4	321	Q9NRR5
PLGSRPRQPNLIPWA	TFR2	61	Q9UP52
RALGPLRTPAPPLWI	UNQ9165/PRO28630	6	Q6UXU0
RNPTPRGFLKPLINW	nan	71	Q96M85
LPAPSWRALSGLLPP	LRIG2	61	O94898
SPQSPQLIRRGPRLW	NDC1	471	Q9BTX1